Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 4Gynecologic 3Sarcoma 1Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 2Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Carboplatin 62Paclitaxel 61Specimen Handling 37Cisplatin 37Taxes 35Magnetic Resonance Spectroscopy 31Bevacizumab 30Immunoglobulin G 23Disulfides 23Biopsy 22Cyclophosphamide 19aldesleukin 17Topotecan 16Brachytherapy 16Radiotherapy 15Gemcitabine 15veliparib 14Oxaliplatin 13Doxorubicin 13temsirolimus 12fludarabine 12Platinum 12Docetaxel 121,2-diaminocyclohexaneplatinum II citrate 12olaparib 11liposomal doxorubicin 10cediranib 10Sirolimus 10Radiation 9Nivolumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Tirapazamine × Gynecologic × Clear all
NCT00262821 2019-07-23

Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Terminated
402 enrolled 18 charts
Gynecologic

Uterine Cervical Neoplasms

NCT00098995 2013-06-26

Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

National Cancer Institute (NCI)

Phase 1 Completed
22 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00020696 2012-01-10

Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡